Product image of Methylprednisolone Pfizer (Methylprednisolone Sodium Succinate) supplied by GNH India

Methylprednisolone Pfizer

Active Ingredient:
Methylprednisolone Sodium Succinate
Origin:
EU

Methylprednisolone Pfizer (Methylprednisolone Sodium Succinate)

Methylprednisolone sodium succinate, the active ingredient in Methylprednisolone Pfizer, is a corticosteroid presented as an injectable solution for intramuscular and intravenous administration. It is used to manage acute inflammatory disorders, severe allergic reactions, asthma exacerbations, rheumatic diseases, and various dermatologic conditions in both adult and pediatric patients under medical supervision.

GNH India supplies Methylprednisolone Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory documentation to support global distribution.

Manufacturer / TM Owner

Pfizer Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylprednisolone sodium succinate is indicated for a range of inflammatory and immune‑mediated conditions.

  • Inflammatory disorders: rapid reduction of tissue inflammation and associated pain.
  • Allergic reactions: suppression of severe hypersensitivity responses and airway edema.
  • Asthma exacerbations: prompt reversal of bronchial inflammation to improve airflow.
  • Rheumatic diseases: control of joint swelling and systemic inflammation.
  • Dermatologic conditions: alleviation of severe skin inflammation and immune‑driven eruptions.

How It Works

  • Methylprednisolone sodium succinate enters cells and binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus. This complex interacts with glucocorticoid response elements on DNA, modulating transcription of anti‑inflammatory proteins while repressing pro‑inflammatory cytokine genes, thereby producing potent immunosuppressive and anti‑inflammatory effects.

Side Effects

Adverse reactions may vary with dose, duration, and individual susceptibility.

Common Side Effects

  • Hyperglycemia: elevated blood sugar levels, especially in diabetic patients.
  • Fluid retention: peripheral edema and weight gain.
  • Mood changes: irritability, anxiety, or insomnia.
  • Increased appetite: leading to weight gain.
  • Headache: mild to moderate intensity.
  • Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects

  • Adrenal suppression: risk of insufficiency after abrupt discontinuation.
  • Severe infection: heightened susceptibility to bacterial, viral, or fungal pathogens.
  • Anaphylaxis: rare but potentially life‑threatening allergic reaction.
  • Osteonecrosis: bone tissue death, particularly with high‑dose or prolonged therapy.
  • Psychosis: severe mood or thought disturbances.
  • Severe hypertension: marked increase in blood pressure.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications.

  • Assess infection risk: evaluate for active infections before initiating therapy.
  • Monitor blood glucose: patients with diabetes may require dose adjustment.
  • Screen psychiatric history: corticosteroids can exacerbate mood disorders.
  • Consider bone health: prolonged use may lead to osteoporosis; supplement with calcium and vitamin D as appropriate.
  • Avoid abrupt discontinuation: taper dose to prevent adrenal insufficiency.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Methylprednisolone may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Live vaccines: may suppress immune response, avoid concurrent administration.
  • Strong CYP3A4 inducers (e.g., rifampin): may reduce corticosteroid efficacy.
  • Anticoagulants (warfarin): increased risk of bleeding.

Moderate Interactions (Monitor Closely)

  • NSAIDs: increased risk of gastrointestinal ulceration and bleeding.
  • Diabetes medications: may require dose adjustment due to hyperglycemia.
  • Antihypertensives: corticosteroids may blunt antihypertensive response.

Frequently Asked Questions

Methylprednisolone Pfizer is an injectable corticosteroid used to treat a variety of acute inflammatory and immune‑mediated conditions, including severe allergic reactions, asthma attacks, rheumatic diseases, inflammatory skin disorders, and other inflammatory disorders where rapid anti‑inflammatory action is required.

The drug penetrates cells and binds to intracellular glucocorticoid receptors. This complex then moves to the nucleus, where it binds glucocorticoid response elements on DNA, altering gene transcription to increase anti‑inflammatory proteins and suppress pro‑inflammatory cytokines, resulting in potent immunosuppression.

The appropriate dose is individualized by the prescribing clinician based on the specific indication, severity of the condition, patient weight, age, renal and hepatic function, and any concomitant therapies. No fixed regimen is provided here; dosing decisions are made by qualified healthcare professionals.

Methylprednisolone is classified as pregnancy category unknown; it should only be used when the potential benefit justifies any potential risk to the fetus. Limited data exist for breastfeeding, and the drug may be excreted in milk, so a risk‑benefit assessment is required.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Methylprednisolone is a synthetic glucocorticoid with intermediate‑to‑high potency and a relatively rapid onset of action compared with agents like hydrocortisone. It offers greater anti‑inflammatory effect per milligram and is often preferred for acute severe inflammation, while having a similar safety profile to other systemic corticosteroids.

The injectable solution should be stored at 2‑8 °C (refrigerated). Keep it in the original packaging, protect from light, and do not freeze or shake the vial. If temperature excursions occur, consult the product’s stability data before use.

Methylprednisolone is given by intramuscular or intravenous injection, as directed by a healthcare professional. The route, rate of infusion, and dilution are determined by the clinical situation and the prescribing physician’s protocol.

Serious risks include adrenal suppression, severe infections, anaphylactic reactions, osteonecrosis, psychosis, and marked hypertension. Patients should be monitored for signs of infection, unexplained mood changes, bone pain, and blood pressure elevations, especially during high‑dose or prolonged therapy.

Methylprednisolone is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and in those with systemic fungal infections. Caution is advised for individuals with uncontrolled diabetes, active viral infections, or a history of severe psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.